Celldex Therapeutics | CLDX - Debt

Stock Price
30.06
Daily Change
5.22 21.01%
Monthly
13.14%
Yearly
45.71%
Q1 Forecast
22.31

Celldex Therapeutics reported $2.62M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Agenus USD 35.54M 2.34M Mar/2025
Amgen USD 54.59B 1.62B Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Celldex Therapeutics USD 2.62M 410K Sep/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
Nektar Therapeutics USD 0 0 Jun/2022
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 60.85B 78M Sep/2025
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025